Oxyntomodulin: The Dual-Action Gut Hormone Shaping the Future of Metabolic Therapy
Abstract Oxyntomodulin (OXM), a 37-amino-acid peptide derived from the proglucagon precursor, has long existed in the shadows of better-known incretin hormones like GLP-1. However, its ability to activate both the GLP-1 and glucagon receptors—albeit with modest affinity—has recently propelled it to the forefront of metabolic research. Originally identified for its role in inhibiting gastric acid […]
LinkPeptide